COMMUNIQUÉS West-GlobeNewswire

scPharmaceuticals Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
19/03/2025
scPharmaceuticals generated fourth quarter 2024 net FUROSCIX ® revenue of $12.2 million, and full year 2024 revenue of $36.3 million Cash and cash equivalents of $75.7 million as of December 31, 2024 U.S. Food and Drug [...]
Rhythm Pharmaceuticals Announces Orphan Drug Designation Granted to Setmelanotide for Treatment of Hypothalamic Obesity in Japan
19/03/2025
BOSTON, March 19, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine [...]
iCAD Reports Financial Results for Fourth Quarter and Fiscal Year Ended December 31, 2024
19/03/2025
NASHUA, N.H., March 19, 2025 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) ("iCAD" or the "Company") a global leader on a mission to create a world where cancer can’t hide by providing clinically proven AI-powered [...]
Akebia Therapeutics Announces Proposed Public Offering of Common Stock
19/03/2025
CAMBRIDGE, Mass., March 19, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics ® , Inc. (“Akebia”) (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today [...]
Inventiva announces the schedule of publication and presentation of its 2024 Full-Year Financial Results
19/03/2025
Daix (France), New York City (New York, United States), March 19, 2025 – Inventiva (Euronext Paris and NASDAQ: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development [...]
Inventiva annonce la date de publication et de présentation de ses résultats financiers 2024
19/03/2025
Daix (France), New York City (New York, Etats-Unis), le 19 mars 2025 – Inventiva (Euronext Paris et NASDAQ : IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement clinique [...]
Opus Genetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
19/03/2025
RESEARCH TRIANGLE PARK, N.C., March 19, 2025 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage ophthalmic biopharmaceutical company developing important new therapies for the treatment of inherited [...]
BioPorto announces guidance for 2025 and aspirations for 2026 towards 2029
19/03/2025
March 19, 2025 Announcement no. 05 BioPorto announces guidance for 2025 and aspirations for 2026 towards 2029 Copenhagen, Denmark, March 19, 2025, (GLOBE NEWSWIRE) – BioPorto A/S (BioPorto or Company) (CPH:BIOPOR), an [...]
BiomX to Report Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025
19/03/2025
NESS ZIONA, Israel, March 19, 2025 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage company advancing novel natural and engineered phage therapies that target specific [...]
Comprehensive Urology in Los Angeles Launches TEM-C Study for Chronic UTIs
19/03/2025
LOS ANGELES, March 19, 2025 (GLOBE NEWSWIRE) -- Comprehensive Urology launches its new observational study, TEM-C for Chronic Urinary Tract Infections (UTIs) for women under the expert guidance of Principal Investigator [...]
Trading in GN Store Nord shares by board members, executives and associated persons
19/03/2025
GN Store Nord has received notification pursuant to article 19 of regulation (EU) no. 596/2014 of the below transactions related to shares in GN Store Nord made by persons discharging managerial responsibilities in GN [...]
Prevent Child Abuse America Launches Groundbreaking Public Service Campaign to Prevent Child Abuse Before It Happens
19/03/2025
CHICAGO, March 19, 2025 (GLOBE NEWSWIRE) -- Prevent Child Abuse America, a leading advocate for child well-being, is proud to announce the launch of a new public service campaign aimed at raising awareness and promoting [...]
Bioxytran Signs NDA with the University of Georgia to Evaluate Galectin Antagonists for Bird Flu Treatment in Chickens
19/03/2025
In Vitro studies have shown promise against viruses similar to the bird flu virus BOSTON, MASSACHUSETTS, March 19, 2025 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a clinical stage biotechnology [...]
Genenta Announces €20 million ($21.9M) Financing To Expand Pipeline As Brain Tumor Trial Is Showing Promising Survival Rates
19/03/2025
MILAN and NEW YORK, March 19, 2025 (GLOBE NEWSWIRE) -- Genenta Science (Nasdaq: GNTA), a pioneer in immuno-oncology and a leader in cell-based therapeutics, today announced a €20 million ($21.9 million) financing [...]
InformedDNA Acquires Coriell Life Sciences, Expanding Precision Health Capabilities
19/03/2025
Precision health leader adds Coriell’s pharmacogenomics capabilities to expand the application of genomics and increase patient access to more personalized and effective health care ST. PETERSBURG, Fla., March 19, 2025 [...]
Prime Biome Reviewed: A Prime Biome Expert's Guide to Avoiding Fakes and Ensuring Authenticity
19/03/2025
ST. PETERSBURG, Fla., March 19, 2025 (GLOBE NEWSWIRE) -- Prime Biome is a leading skin and gut microbiome rejuvenation supplement that has taken the wellness world by storm. This innovative formula—offered as delicious [...]
Arialief Reviews 2025: Consumer Reports on Arialief Nerve Health Supplement
19/03/2025
AURORA, Colo., March 19, 2025 (GLOBE NEWSWIRE) -- Arialief is quickly gaining a reputation as a transformational supplement in the field of nerve health. For years, those suffering from neuropathy, sciatica, and chronic [...]
Femasys Announces Partnership with CNY Fertility, National Conglomerate Network of Fertility Centers, to Offer FemaSeed in its 11 Locations
19/03/2025
Femasys continues to expand access and market share for its first-line infertility treatment option ATLANTA, March 19, 2025 (GLOBE NEWSWIRE) -- Femasys, Inc., (Nasdaq: FEMY), a leading biomedical innovator addressing [...]
Iridex Announces Strategic Investment in the Company
19/03/2025
MOUNTAIN VIEW, Calif., March 19, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems and delivery devices for the treatment of [...]

Pages